STAT

He can shame Pfizer and others, but Trump doesn’t have a practical way to lower drug prices

Trump can threaten all he wants. But his ranting reveals an inability to accept that delivering on his promise will be much harder than he realized.
Source: Chip Somodevilla/Getty Images

Even in the boardrooms of Pfizer, they had to have expected President Trump’s Twitter outburst on Monday. If anything, the Pfizer executives set themselves up to be a target.

Let’s look back to the end of May, when Trump promised that some big drug makers would take “voluntary, massive” price cuts in two weeks.

Well, it’s been close to six weeks and, so far, most large brand-name drug makers , although few companies raised prices by any meaningful amount, either. This is a time of year,

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly Buying A Plant, A Pfizer Antibiotic, And More
Eli Lilly agreed to acquire a manufacturing facility in Wisconsin from Nexus Pharmaceuticals to produce injectable medicines amid shortages of Mounjaro and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Drug Shortages, Medicare Spending On An Alzheimer’s Drug, And More
Medicare estimates a new Alzheimer’s drug could cost the program billions of dollars by next year — well beyond what Wall Street or the drug’s manufacturer project.
STAT2 min readCrime & Violence
STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.

Related Books & Audiobooks